Rare Disease
Leber Hereditary Optic Neuropathy: A Giving Smarter Guide
Leber Hereditary Optic Neuropathy: A Giving Smarter Guide
It is believed that there are as many as 8,000 rare diseases collectively affecting one in ten people around the world. These diseases are extremely difficult to diagnose, in part because there is little recognition of the symptoms or consensus on diagnostic criteria. For example, some people with rare diseases can go as many as ten years (and some have gone even longer) before getting to a proper diagnosis, only to find that treatments are hard to come by, ineffective, and/or cause debilitating side effects. They also may experience the loneliness and hopelessness that results from a condition that is not widely discussed, and are thus less likely to have a community that provides support or empathy.
From misophonia to sarcoidosis, the Milken Institute has worked with donors with firsthand experience of rare and difficult to diagnose conditions, bringing experts from multiple sectors and fields together with patients [people with lived experiences] to understand the landscape and work toward better diagnostics and treatments.
Current Research Programs
CAMK2-Related Neurodevelopmental Disorders
Leber Hereditary Optic Neuropathy
Misophonia
Rare Disease
Highlights
-
The Value of Collaboration in Rare Disease Research
Philanthropy, Collaboration, and Advocacy Overcome Roadblocks at the Intersection of Cancer and Rare Disease Hearing the words “You have cancer” is life-changing—even more so when your cancer is one that doctors very rarely see. This is...Read ArticleImage
Caitlyn Barrett, PhD
Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyCaitlyn Barrett, PhD, is a director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. Her scientific expertise in cancer biology and neurodegeneration in addition to her experience in grant and program management, stakeholder engagement, and program analysis are brought to bear as she partners with philanthropists to maximize their impact on the biomedical ecosystem. -
The Power of Community for Rare Disease Research
Collaboration, communication, and community are the foundation for meaningful progress in any field. For individuals living with a rare disease, it means even more: A supportive community can alleviate feelings of isolation and foster...Read ArticleImage
Quinton Banks, PhD
Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyQuinton Banks,PhD, is an associate director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. His extensive scientific background includes research into chronic pain, taste perception, and muscle physiology. -
Strategic Philanthropy Can Bridge a Rare Disease that Causes Blindness with Common Neurodegenerative Disorders
For the 200 million Americans who wear eyeglasses, blurry vision is often the symptom that leads to an eye exam and a prescription for corrective lenses. However, for about 100 Americans each year, blurry vision is an early symptom of a...Read ArticleImage
Nadia Penrod, PhD
Associate Director, Science Philanthropy Accelerator for Research and Collaboration (SPARC) team, Milken Institute Strategic PhilanthropyNadia Penrod,PhD, is an associate director on the Science Philanthropy Accelerator for Research and Collaboration (SPARC) team at Milken Institute Strategic Philanthropy. In this role, she leverages her expertise as an interdisciplinary scientist in biomedicine and informatics to identify high-impact opportunities for philanthropic investment that promote science for the public good and have the potential to transform health.
Our Team
Cara Altimus, PhD
Caitlyn Barrett, PhD
Elizabeth Burke, PhD
Ishtiaq Mawla, PhD